A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in PONV
Status:
Recruiting
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled Dose-Finding study. About
200 subjects undergoing elective laparoscopic abdominal or gynecological surgery are planned
to be enrolled and randomized into four groups by a ratio of 1:1:1:1.